Larry Biegelsen
Stock Analyst at Wells Fargo
(3.80)
# 679
Out of 5,123 analysts
358
Total ratings
54.55%
Success rate
7.01%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Overweight | $125 → $94 | $75.50 | +24.50% | 16 | Feb 5, 2026 | |
| TFX Teleflex | Maintains: Equal-Weight | $139 → $116 | $106.00 | +9.43% | 9 | Jan 29, 2026 | |
| HTFL HeartFlow | Initiates: Overweight | $38 | $28.14 | +35.04% | 1 | Jan 28, 2026 | |
| JNJ Johnson & Johnson | Maintains: Overweight | $230 → $240 | $234.47 | +2.36% | 15 | Jan 22, 2026 | |
| PEN Penumbra | Downgrades: Equal-Weight | $374 | $339.92 | +10.03% | 20 | Jan 15, 2026 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $160 → $145 | $68.23 | +112.52% | 15 | Jan 14, 2026 | |
| KMTS Kestra Medical Technologies | Maintains: Overweight | $27 → $28 | $25.58 | +9.46% | 3 | Dec 12, 2025 | |
| COO The Cooper Companies | Maintains: Equal-Weight | $72 → $82 | $80.92 | +1.33% | 20 | Dec 5, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $95 → $96 | $79.77 | +20.35% | 18 | Dec 5, 2025 | |
| MDT Medtronic | Maintains: Overweight | $100 → $114 | $101.84 | +11.94% | 19 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $452 → $456 | $360.66 | +26.43% | 17 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.55 | +2.72% | 9 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $95 | $79.37 | +19.69% | 12 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $14 | $18.99 | -26.28% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $10 | $7.94 | +25.94% | 15 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $93 | $70.82 | +31.32% | 10 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $122 | $114.67 | +6.39% | 17 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $89 → $87 | $82.63 | +5.29% | 5 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $599 → $600 | $478.49 | +25.39% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $0.68 → $0.85 | $1.12 | -24.11% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Equal-Weight | $93 | $79.06 | +17.63% | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $3 | $1.49 | +101.34% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $21.03 | +14.12% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $11.56 | +25.43% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $113 → $98 | $88.09 | +11.25% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $16.09 | +5.66% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $11.08 | +342.24% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $108.20 | +25.69% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $87.06 | -19.60% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $207.87 | +29.89% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $65.93 | - | 2 | Nov 2, 2017 |
Boston Scientific
Feb 5, 2026
Maintains: Overweight
Price Target: $125 → $94
Current: $75.50
Upside: +24.50%
Teleflex
Jan 29, 2026
Maintains: Equal-Weight
Price Target: $139 → $116
Current: $106.00
Upside: +9.43%
HeartFlow
Jan 28, 2026
Initiates: Overweight
Price Target: $38
Current: $28.14
Upside: +35.04%
Johnson & Johnson
Jan 22, 2026
Maintains: Overweight
Price Target: $230 → $240
Current: $234.47
Upside: +2.36%
Penumbra
Jan 15, 2026
Downgrades: Equal-Weight
Price Target: $374
Current: $339.92
Upside: +10.03%
Inspire Medical Systems
Jan 14, 2026
Maintains: Overweight
Price Target: $160 → $145
Current: $68.23
Upside: +112.52%
Kestra Medical Technologies
Dec 12, 2025
Maintains: Overweight
Price Target: $27 → $28
Current: $25.58
Upside: +9.46%
The Cooper Companies
Dec 5, 2025
Maintains: Equal-Weight
Price Target: $72 → $82
Current: $80.92
Upside: +1.33%
Edwards Lifesciences
Dec 5, 2025
Maintains: Overweight
Price Target: $95 → $96
Current: $79.77
Upside: +20.35%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $100 → $114
Current: $101.84
Upside: +11.94%
Nov 14, 2025
Maintains: Overweight
Price Target: $452 → $456
Current: $360.66
Upside: +26.43%
Nov 14, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.55
Upside: +2.72%
Nov 14, 2025
Maintains: Overweight
Price Target: $103 → $95
Current: $79.37
Upside: +19.69%
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $13 → $14
Current: $18.99
Upside: -26.28%
Nov 6, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $7.94
Upside: +25.94%
Oct 31, 2025
Maintains: Overweight
Price Target: $98 → $93
Current: $70.82
Upside: +31.32%
Oct 30, 2025
Maintains: Overweight
Price Target: $120 → $122
Current: $114.67
Upside: +6.39%
Oct 30, 2025
Maintains: Overweight
Price Target: $89 → $87
Current: $82.63
Upside: +5.29%
Oct 22, 2025
Maintains: Overweight
Price Target: $599 → $600
Current: $478.49
Upside: +25.39%
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.12
Upside: -24.11%
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $79.06
Upside: +17.63%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.49
Upside: +101.34%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $21.03
Upside: +14.12%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $11.56
Upside: +25.43%
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $88.09
Upside: +11.25%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $16.09
Upside: +5.66%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $11.08
Upside: +342.24%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $108.20
Upside: +25.69%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $87.06
Upside: -19.60%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $207.87
Upside: +29.89%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $65.93
Upside: -